We are live on
!
Find out more
Milestone Pharmaceuticals
MIST
MIST
44 hedge funds and large institutions have $56.4M invested in Milestone Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
83% more capital invested
Capital invested by funds: $30.9M → $56.4M (+$25.5M)
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
10% more funds holding
Funds holding: 40 → 44 (+4)
3.75% more ownership
Funds ownership: 55.24% → 58.99% (+3.7%)
86% less call options, than puts
Call options by funds: $6K | Put options by funds: $42K
Holders
44
Holders Change
+4
Holders Change %
+10%
% of All Funds
0.63%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
12
Increased
12
Reduced
8
Closed
7
Calls
$6K
Puts
$42K
Net Calls
-$36K
Net Calls Change
-$287K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$3.31M |
| 2 |
O
OrbiMed
New York
|
+$3.25M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.84M |
| 4 |
BlackRock
New York
|
+$2.76M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.37M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$1.54M |
| 2 |
Morgan Stanley
New York
|
-$908K |
| 3 |
Barclays
London,
United Kingdom
|
-$414K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$55.6K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$33.7K |
